Tissue Regenix Share Price (TRX)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Tissue Regenix	LSE:TRX	London	Ordinary Share	GB00B5SGVL29	ORD 0.5P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	8.50p	26,586	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
8.00p		9.00p	8.50p	8.50p	8.50p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	5.23	-10.77	-1.00		99.6

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Venn Life (VENN), Port Erin (PEBI)

Tissue Regenix (TRX) Latest News

Tissue Regenix News

Date	Time	Source	Headline
03/9/2018	09:18	ALNC	Tissue Regenix Interim Loss Narrows As Revenue Jumps On CellRight Deal
03/9/2018	07:22	ALNCF	Alliance News Flash Headline
03/9/2018	07:00	UKREG	Tissue Regenix Group PLC Unaudited Interim Results
02/8/2018	07:02	UKREG	Tissue Regenix Group PLC Notice of Interim Results
04/7/2018	10:21	ALNC	Tissue Regenix Poaches Applied Graphene Finance Chief
04/7/2018	07:00	UKREG	Tissue Regenix Group PLC Appointment of CFO
25/6/2018	11:12	ALNC	Tissue Regenix Secures Import License And Signs Distribution Agreement
25/6/2018	07:00	UKREG	Tissue Regenix Group PLC HTA License granted and UK distribution Agreement
21/6/2018	07:10	RNSNON	Tissue Regenix Group PLC TRX BioSurgery wins GPO Supplier Horizon Award
18/6/2018	07:00	UKREG	Tissue Regenix Group PLC Issue of Equity

More Tissue Regenix News

Tissue Regenix Takeover Rumours

Tissue Regenix (TRX) Share Charts

1 Year Tissue Regenix Chart

1 Month Tissue Regenix Chart

Intraday Tissue Regenix Chart

Tissue Regenix (TRX) Discussions and Chat

Tissue Regenix Forums and Chat

Date	Time	Title	Posts
04/9/2018	07:58	Tissue Regenix delivering practical solutions to real clinical issues	2,073
14/3/2018	17:13	Torex - an insiders tale	24
24/5/2016	10:30	Third time lucky	6,918
29/6/2013	21:26	TOREX 2007 - THE TILLS RING AT LAST	8
24/9/2012	10:10	Torex Retailing	8

Add a New Thread

Tissue Regenix (TRX) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-10-15 14:01:27	8.58	24,240	2,079.77	O
2018-10-15 12:34:30	8.00	500	40.00	O
2018-10-15 07:01:38	8.02	1,846	148.05	O

View all Tissue Regenix trades in real-time

Tissue Regenix (TRX) Top Chat Posts

Date	Subject
15/10/2018 09:20	Tissue Regenix Daily Update: Tissue Regenix is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 8.50p. Tissue Regenix has a 4 week average price of 8.38p and a 12 week average price of 8.25p. The 1 year high share price is 11.75p while the 1 year low share price is currently 5.63p. There are currently 1,171,730,823 shares in issue and the average daily traded volume is 84,571 shares. The market capitalisation of Tissue Regenix is £99,597,119.96. Read Full Thread Reply
07/6/2018 14:43	channel pirate: Quiet on here whilst we all wait for some good news to be announced. The 16988 shares showing as a "sell" at 10.975p today is actually my "BUY". Sold some of these a little while back and bought them back today £100 cheaper, not a lot I know, but sold a different share yesterday for £800 profit, so thought I would put it toward rounding up my holding here. C'mon Mr Couldwell, an update might just get the share price moving in the right direction again. Read Full Thread Follow Reply
26/2/2018 07:17	channel pirate: 2 X RNS's today !! Let's hope we get some positive share price lifting results on 19th March then: 26/02/2018 7:01am UK Regulatory (RNS & others) Tissue Regenix (LSE:TRX) Intraday Stock Chart Today : Monday 26 February 2018 Click Here for more Tissue Regenix Charts. TIDMTRX RNS Number : 8568F Tissue Regenix Group PLC 26 February 2018 Tissue Regenix Group plc Notice of Results Leeds, 26 February 2018 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces it will release its unaudited preliminary results for the year ended 31 December 2017 on Monday 19 March. Further information regarding an analyst call will follow in due course. For more Information: Tissue Regenix Group plc Tel: 0330 Caitlin Pearson Head of Communications 430 3073 / 07920272 441 ---------------------------------------- ------------ Jefferies International Ltd Tel: 020 Simon Hardy / Christopher Binks 7029 8000 ---------------------------------------- ------------ FTI Consulting Tel: 0203 Brett Pollard / Mo Noonan/ Rob Winder 727 1000 Read Full Thread Follow Reply
25/8/2017 20:52	channel pirate: Well the company are good at manufacturing tissue to repair / heal wounds etc, so maybe they ought to manufacture a positive RNS that will repair the share price which has been severely wounded over the past few months !! Read Full Thread Follow Reply
11/8/2017 15:05	andrewbaker: Adding to and following on from post 1934 in June, it's heartening to know that even a business that's not blessed with the best management, can become compelling when the product is really good and the share price way too low. What we really need is better figures, and better management; then this can really go. I'd buy more, but I'm already loaded to the gills, and can't destabilise my portfolio by doing so: so ... you guys drink your fill, and enjoy what should be, better late that never, a big rise northwards (and more northwards than before, too). ... Couldn't resist it: bought another 15,000 at 13.95p. I'm holding a heck of a lot more, so ok for this top-up, IMHO. lol. :) Read Full Thread Follow Reply
22/6/2017 09:52	channel pirate: With the share price having lost just over 35.36% in the last 6 months, then we could do with some good supporting news right now, or like "yesterday" and not "tomorrow". I have built a nice size holding during these past 6 months, but will not be panic selling or adding more until we get some positive news from the company. Read Full Thread Follow Reply
29/5/2017 07:49	channel pirate: Morning bamboo2, Guessing, then the new Holdings Company has been inaugurated to acquire acquisitions the Main Company has in their sights as being beneficial to the Main Company – hence the recent RNS regarding CellRight Technologies, LLC ("CellRight"). To me then this indicates the Company is getting “stronger̶1; all round and is expanding, generating more income etc, both of which has not yet been updated to the market. I would expect the large shareholders (Invesco, Woodford etc) are already briefed what is happening, especially with the share price languishing at the present low price, which must have knocked millions off the value of their holdings. I’m looking forward to the Prelims, and let’s hope it reassures us small pi’s also that we have “boarded the right train”. Read Full Thread Follow Reply
24/4/2017 12:54	channel pirate: Thought I would send an email to Investor Relations at the company this morning - will post the reply should I get one............. Good morning Caitlin, Being a shareholder with a six figure holding it is sad to see some shareholders exiting due to a falling share price and a lack of updates from the company. This time last year the company had already announced via the market of when it was going to report it’s Accounts & Report for the preceding year. Can you advise me of when we are likely to hear from the company in respect of progress and the last financial years Accounts. Thanking you in anticipation. Kind Regards, Read Full Thread Follow Reply
13/2/2017 15:33	channel pirate: Just been looking back through some of the company announcements over the last few months which re-assures me of my holding and maybe that on this dip, or subsequent dips, then it might be prudent to start adding again. From the announcement on 28th November : “The launch of OrthoPure™ XT remains on track for H1 2017, with CE mark approval in the same period. The first distribution agreements within Europe have been signed, indicators of the strong commercial and clinical support for OrthoPure™ XT, in preparation for rapid commercialisation in key European markets once approval is granted. Peter Hamer, Commercial Director TRX Orthopaedics Ltd: "We are extremely encouraged by the initial results returned from the study. Having entered our first distributor agreements, which highlight the demand and market opportunity for OrthoPure™ XT, we remain on track for launch of OrthoPure™ XT by the end of H1 2017.” So anytime in the next 4 months if all goes to plan, and that should see a significant rise in the share price if we are lucky ?? Read Full Thread Follow Reply
27/7/2016 07:08	multibagger: Hi Swiss Paul, Some very valid and searching questions. The biotech/healthcare product market is a very complex one due to various procurement and payment schemes/methods. In the UK, the NHS is a slow adopter and constrained by cost.The US is a much higher cost healthcare system and if TRX finds traction there, then there will be an uplift in share price. Though I keep an eye on TRX, I am not of the view that the share price will move upwards fast and not invested currently. I'm not a fan of either Odell or Samuels having met them both in Leeds at the AGM a few years ago, when I was the only shareholder present ! I'm not convinced about their their tech pipeline either, as regenerative medicine is moving a lot quicker than TRX are. I sold out not long after. My approach to biotech investing has changed and now largely go for funds....I hold AXA Framlington Biotech though I made good money from SCLP, SUMM and SAR in the past.Cyprotex (CRX) is moving in the right direction and their R&D product delivery and commercialisation is much more attractive - I pointed it out here when it was about 60p on this board - now about 135p. I hope TRX comes good for all holders - but my take is that investors may have a fairly long wait. Good luck all :) Read Full Thread Follow Reply
02/1/2014 12:50	multibagger: Hi BB2...my discussion and points of view are largely academic....market seems to be supportive of an upward trending TRX share price and I am certainly not complaining :) The market is what matters and decides the share price, not my opinion ! Read Full Thread Follow Reply

Tissue Regenix share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:40 V: D:20181016 05:21:47